Dyslipidaemia is characterized by increased blood levels of total or LDL cholesterol and
triglycerides, or decreased HDL cholesterol levels, and is a risk factor for cardiovascular …

Dyslipidaemia accelerates the atherosclerotic process and its morbid consequences; statins
represent the evidence-based treatment of choice for reducing low-density lipoprotein …

A food can be regarded as 'functional'if it can demonstrate a beneficial efficacy on one or
more target functions in the body in a convincing way. Beyond adequate nutritional qualities …

Hyperlipidemia is one of the major risk factor for the development of cardiovascular disease.
Hypolipidemic nutraceuticals and functional foods help improve serum lipid profiles as …

Current evidence shows that cholesterol management either reduces the likelihood of
cardiovascular disease (CVD) or slows down its progression. Hence, it is important that all …

Abstract Purpose of Review The aim of this review is to summarize the available clinical
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …

Hypercholesterolemia represents a significant risk for cardiovascular disease (CVD). While
diet intervention remains the initial choice for the prevention and treatment of CVD, the …

Hypercholesterolemia is a predominant risk factor for atherosclerosis and associated
coronary and cerebrovascular diseases. Control of cholesterol levels through therapeutic …

Coronary heart disease (CHD) remains a major source of morbidity and mortality. As the
epidemic of obesity, diabetes, and hypertension continues to grow among young adults, the …

Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease and a healthy
lifestyle is the first line of therapy for treatment. A healthy dietary pattern is a cornerstone for …